Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00261612
Status:
UNKNOWN
Last Update Posted:
2006-10-18
First Post:
2005-12-01
Brief Title:
Bortezomib Rituximab and Dexamethasone BORID for RelapsedRefractory Mantle Cell Lymphoma
Sponsor:
Medical University of Vienna
Organization:
Medical University of Vienna
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma Mantle-Cell |
Keywords:
| Name | View |
|---|---|
| relapsed or chemotherapy-refractory disease | View |